Oncology
Characteristics and Treatment Patterns of Nontransplanted Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in the Frontline Setting
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.